Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc. > Volume on the Nasdaq
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(499)
•••
Comment by Oldweedon May 05, 2021 1:37pm
235 Views
Post# 33133112

RE:RE:Volume on the Nasdaq

RE:RE:Volume on the Nasdaq
CommonCentsforDollars wrote: What is funny is how we continue to post on the APHA board. 

I expect when the merger was announced completed there was some rebalancing in cannabis ETF's that held both APHA and TLRY. Should be about done now.


Oldweed wrote: Although here is heavy volume on the Nas the price has not moved much, I'm thinking this is in part due to Algo's and funds trying to repositon and cover their shorts. Noone in the sector is coming close to our volumes. 


I would not be surprised to se this SP surpass CGC before TLRY announces a partnership as I thik we are at our floor and theirs is nowhere in sight. Will be interesting to see how the large caps battle this out for sure.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities